CHIRON INVESTMENT MANAGEMENT, LLC Supernus Pharmaceuticals, Inc. Transaction History

CHIRON INVESTMENT MANAGEMENT, LLC portfolio value:

$137,000
portfolio value

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 4.05K shares 137K $33.85 4.05K